House Lawmaker Probes Top PBMs for 'Punitive' Audits of Independent Pharmacies

A key House lawmaker has launched an investigation into whether the three largest pharmacy benefit managers (PBMs) — CVS Caremark, Cigna's Express Scripts, and UnitedHealth's Optum Rx — used retaliatory audits to punish independent pharmacies. The probe centers on allegations that these PBMs conducted aggressive, 'punitive' audits that imposed heavy financial penalties on smaller pharmacies, often over minor clerical errors, potentially driving them out of business. The lawmaker is demanding documents and data to determine if the audits were disproportionately aimed at independent pharmacies that had challenged PBM reimbursement rates or steering practices. This matters because PBMs control prescription drug pricing and access for millions of Americans, and independent pharmacies are often the only option in rural and underserved areas. If proven, such practices could violate federal antitrust and consumer protection laws. The investigation signals growing bipartisan scrutiny of PBM business practices and could lead to new legislation mandating fair audit standards and greater transparency in PBM-pharmacy contracts. The outcome may shape the future viability of independent pharmacies nationwide.